Considering that upregulation of miR-34a is a common event in many liver diseases and that SIRT1 is frequently involved, we hypothesize that the activation of the miR-34a/SIRT1/p53 signaling pathway is closely related to hepatocytes and contributes to the progress of liver disease. The gene discussed is TP53; the disease is liver disorder.